关键数据
7.700今开
8.185最高
78.07K成交量
3.19市盈率 TTM
107.14市盈率动
--股息TTM
0.10%换手率
7.690昨收
7.620最低
601.79K成交额
亏损市盈率静
1.39市净率
0.00%股息率 TTM
37.51%ROA
13.02052周最高
33.11量比
-17.93M净利润
78.45M总股本
2.4327每股收益TTM
1.46Beta
65.59%ROE
6.13052周最低
7.35%振幅
75.66%毛利率
609.56M总市值
-1.03回报/风险
3.89%风险率

即将为您带来更多新闻,敬请期待。。。
CorMedix Inc评分
-0.02与上次评分对比预测8.40
财务诊断9.32
技术分析3.15
公司估值9.24
机构认同度5.00
风险评估5.52
分析师评级
买入评级
15.333目标均价
+99.39%涨幅空间
CorMedix Inc 最新财报电话会记录
CorMedix (CRMD) 2026年第二季度业绩电话会:营收达1.019亿美元,上调EBITDA指引
CorMedix 2026年第二季度营收达到1.019亿美元,调整后EBITDA为5870万美元,管理层将全年EBITDA指引上调至1.25亿至1.40亿美元。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
CorMedix Inc 简介
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
行业药品
公司代码CRMD
员工数量64
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Deep Track Capital LP | 6.72% |
|---|
| BlackRock Institutional Trust Company, N.A. | 6.45% |
|---|
| Abdalkader (Shaibatalhamd Aymen) | 5.86% |
|---|
| Vanguard Capital Management, LLC | 3.99% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor | 27.10% |
|---|
| Investment Advisor/Hedge Fund | 13.41% |
|---|
| Hedge Fund | 10.76% |
|---|
| Individual Investor | 7.51% |
|---|
常见问题
CorMedix Inc(CRMD)的当前股价是多少?
CorMedix Inc(CRMD)的当前股价是 7.77。
CorMedix Inc股票的52周最高点是多少?
CorMedix Inc股票的52周最高点是13.02。
CorMedix Inc股票的52周最低点是多少?
CorMedix Inc股票的52周最低点是6.13。
现在CorMedix Inc(CRMD)的股票是买入、持有还是卖出?
根据分析师评级,CorMedix Inc(CRMD)的总体评级为买入,目标价格为15.33。
CorMedix Inc(CRMD)股票的每股收益(EPS TTM)是多少
CorMedix Inc(CRMD)股票的每股收益(EPS TTM)是2.43。